Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins

Journal of Neuroimmunology

Volumn 122, Issue 1-2, 2002, Pages 159-166

  Semra, Y K ^a   Seidi, O A ^a   Sharief, M K ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Disease activity; IAP proteins; Multiple sclerosis

Indexed keywords

CELL PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; ISOPROTEIN; MITOGENIC AGENT; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; X CHROMOSOME LINKAGE;

ADULT; ANTIGENS, CD95; APOPTOSIS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INSECT PROTEINS; MALE; MIDDLE AGED; MITOGENS; MULTIPLE SCLEROSIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES;

EID: 0036147325     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00464-7     Document Type: Article

References (45)

1. Multiple sclerosis - Emerging concepts of disease pathogenesis
2. Biochemical pathways of caspase activation during apoptosis
3. Apoptotic effector pathways in autoimmunity
4. Defective T cell Fas function in patients with multiple sclerosis
5. Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS
6. Lipopolysaccharide induces the expression of cellular inhibitor of apoptosis protein-2 in human macrophages
7. IAP family proteins: Suppressors of apoptosis
8. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
9. Endogenous inhibitors of caspases
10. Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction
11. Apoptotic pathways: Paper wraps stone blunts scissors
12. Analysis of the role of Bcl-2 in apoptosis
13. The role of the Bcl-2 family of apoptosis regulatory proteins in the immune system
14. Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS
15. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
16. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation
17. CD95 (APO-1/Fas)-mediated apoptosis: Live and let die
18. CD95's deadly mission in the immune system
19. KIAP, a novel member of the inhibitor of apoptosis protein family
20. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
21. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine
22. T cell signaling: A decision of life and death
23. An exegesis of IAPs: Salvation and surprises from BIR motifs
24. The Bcl-2 family and cell death regulation
25. The effect of apoptosis inhibitors on experimental autoimmune encephalomyelitis: Apoptosis as a regulatory factor
26. The central effectors of cell death in the immune system
27. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
28. Fas(t) track to apoptosis in MS-TNF receptors may suppress or potentiate CNS demyelination
29. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis
30. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis
31. Increased cellular expression of the caspase inhibitor flip in intrathecal lymphocytes from patients with multiple sclerosis
32. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis
33. Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis
34. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
35. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
36. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
37. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
38. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
39. A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis
40. The IAP family: Endogenous caspase inhibitors with multiple biological activities
41. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
42. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
43. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions
44. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand
45. Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis